Free Trial

Stereotaxis Q3 2023 Earnings Report

Stereotaxis logo
$2.35 +0.13 (+5.86%)
(As of 12/20/2024 05:31 PM ET)

Stereotaxis EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.05
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Stereotaxis Revenue Results

Actual Revenue
$7.80 million
Expected Revenue
$8.75 million
Beat/Miss
Missed by -$950.00 thousand
YoY Revenue Growth
N/A

Stereotaxis Announcement Details

Quarter
Q3 2023
Time
N/A
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Stereotaxis Earnings Headlines

Stereotaxis, Medtech announce catheter approved by China’s NMPA
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
See More Stereotaxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stereotaxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stereotaxis and other key companies, straight to your email.

About Stereotaxis

Stereotaxis (NYSEAMERICAN:STXS) designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

View Stereotaxis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings